Mohammed Ali Madkhali
Overview
Explore the profile of Mohammed Ali Madkhali including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
12
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alhazmi L, Oraibi O, Areeshi A, Alhazmi N, Hakami A, Kariri T, et al.
Medicine (Baltimore)
. 2025 Feb;
104(8):e41598.
PMID: 39993102
Bronchial asthma is a common chronic airway disease marked by reversible obstruction and bronchial hyperresponsiveness. Effective management relies on patient understanding of the condition and available treatments. This study aimed...
2.
Mohamed A, Darraj M, Yassin A, Somaili M, Sayed A, Oraibi O, et al.
BMC Endocr Disord
. 2024 Sep;
24(1):197.
PMID: 39304825
Background: Diabetes Mellitus is a major predictor for severity and mortality that is increased by 50% in COVID-19 infection. The aim of this study is to estimate the prevalence of...
3.
Mohrag M, Abdulrasak M, Borik W, Alshamakhi A, Ageeli N, Abu Allah R, et al.
J Clin Med Res
. 2024 Aug;
16(7-8):375-380.
PMID: 39206102
Background: Acute kidney injury (AKI) following cardiac surgery is a well-described phenomenon, usually associated with hemodynamic changes ultimately leading to ischemic injury to the kidneys. In this study, we assessed...
4.
Alqassimi S, Elmakki E, Areeshi A, Aburasain A, Majrabi A, Masmali E, et al.
Medicina (Kaunas)
. 2024 Jun;
60(6).
PMID: 38929557
This study aimed to determine the prevalence of overweight, obesity, and the associated risk factors among medical students at Jazan University in Saudi Arabia. A cross-sectional study was conducted among...
5.
Madkhali M, Abusageah F, Hakami F, Zogel B, Hakami K, Alfaifi S, et al.
Medicina (Kaunas)
. 2024 Jan;
60(1).
PMID: 38256385
: Hydroxyurea is a crucial treatment for sickle cell disease (SCD), but some patients' adherence to it remains suboptimal. Understanding patients' perspectives on SCD and HU is essential for improving...
6.
Oraibi O, Alameer A, Dalak M, Alsharif S, Hakami S, Sumayli M, et al.
Curr Diabetes Rev
. 2024 Jan;
20(8):124-137.
PMID: 38243952
Background: Impaired awareness of hypoglycemia (IAH) is related to a three- to sixfold increase in the risk of severe hypoglycemia in adults with type 1 diabetes mellitus (T1D). This study...
7.
Madkhali M
Medicine (Baltimore)
. 2024 Jan;
103(3):e36936.
PMID: 38241567
Autoimmune disorders place a substantial burden on the healthcare system all over the world affecting almost 3% to 8% of the population. Immune thrombocytopenic purpura (ITP), also known as idiopathic...
8.
Hakami F, Alhazmi E, Busayli W, Althurwi S, Darraj A, Alamir M, et al.
Cureus
. 2023 Dec;
15(12):e50577.
PMID: 38107212
Sickle cell disease (SCD) is a genetic blood disorder that affects hemoglobin and increases stroke risk, particularly in childhood. This review examines the pathophysiological association between SCD and stroke, the...
9.
Madkhali M, Alhazmi E, Hakami F, Darraj H, Hamdi S, Hakami K, et al.
J Multidiscip Healthc
. 2023 Dec;
16:3857-3870.
PMID: 38076592
Background: Lung cancer (LC) is the most common cause of cancer-related deaths worldwide. With lung cancer often diagnosed at advanced stages, understanding the local population's awareness levels is crucial for...
10.
Oraibi O, Somaili M, Elmakki E, Alqassimi S, Madkhali M, Mohrag M, et al.
Endocr Metab Immune Disord Drug Targets
. 2023 Nov;
24(10):1197-1203.
PMID: 37957847
Background: With evolving diabetes technology, continuous glucose monitoring (CGM) and time in range have been advanced as critical measurements to assess complications. They have shown improvement in A1C levels and...